Audra L. Clos

2.1k total citations · 1 hit paper
13 papers, 1.6k citations indexed

About

Audra L. Clos is a scholar working on Molecular Biology, Physiology and Dermatology. According to data from OpenAlex, Audra L. Clos has authored 13 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Physiology and 3 papers in Dermatology. Recurrent topics in Audra L. Clos's work include Alzheimer's disease research and treatments (5 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers) and Cutaneous lymphoproliferative disorders research (3 papers). Audra L. Clos is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers) and Cutaneous lymphoproliferative disorders research (3 papers). Audra L. Clos collaborates with scholars based in United States and Chile. Audra L. Clos's co-authors include Cristian A. Lasagna‐Reeves, Rakez Kayed, George R. Jackson, Diana L. Castillo‐Carranza, Urmi Sengupta, Ivonne Olmedo, Dennisse Gonzalez-Romero, V. M. Sadagopa Ramanujam, Leoncio Vergara and Marcelo J. Kogan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

Audra L. Clos

13 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice

2011 467 citations Cristian A. Lasagna‐Reeves, Diana L. Castillo‐Carranza et al. Molecular Neurodegeneration profile →

Peers

Countries citing papers authored by Audra L. Clos

Since Specialization

Citations

This map shows the geographic impact of Audra L. Clos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audra L. Clos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audra L. Clos more than expected).

Fields of papers citing papers by Audra L. Clos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audra L. Clos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audra L. Clos. The network helps show where Audra L. Clos may publish in the future.

Co-authorship network of co-authors of Audra L. Clos

This figure shows the co-authorship network connecting the top 25 collaborators of Audra L. Clos. A scholar is included among the top collaborators of Audra L. Clos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audra L. Clos. Audra L. Clos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Results of a Phase II Trial of Brentuximab Vedotin for CD30⁺ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis 2015 ·Journal of Clinical Oncology ·Madeleine Duvic, Michael T. Tetzlaff, Pamela Gangar, Audra L. Clos, Dawen Sui, Rakhshandra Talpur	195
2	Firm papules on the penis and scrotum 2014 ·Dermatology Online Journal ·(unknown), Audra L. Clos, Brent Kelly	4
3	Phase II Trial Of Brentuximab Vedotin For CD30+ Cutaneous T-Cell Lymphomas and Lymphoproliferative Disorders 2013 ·Blood ·Madeleine Duvic, Michael T. Tetzlaff, Audra L. Clos, Pamela Gangar, Rakhshandra Talpur	15
4	Association of Skin with the Pathogenesis and Treatment of Neurodegenerative Amyloidosis 2012 ·Frontiers in Neurology ·Audra L. Clos, Rakez Kayed, Cristian A. Lasagna‐Reeves	23
5	Dual role of p53 amyloid formation in cancer; loss of function and gain of toxicity 2012 ·Biochemical and Biophysical Research Communications ·Cristian A. Lasagna‐Reeves, Audra L. Clos, Diana L. Castillo‐Carranza, Urmi Sengupta, Marcos J. Guerrero-Muñoz, Brent Kelly, Richard F. Wagner, Rakez Kayed	71
6	Results of a Phase II Trial of Brentuximab Vedotin (SGN-35) for CD30+ Cutaneous T-Cell Lymphomas and Lymphoproliferative Disorders 2012 ·Blood ·Madeleine Duvic, Michael T. Tetzlaff, Audra L. Clos, Pamela Gangar, Rakhshandra Talpur	4
7	Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice breakdown → 2011 ·Molecular Neurodegeneration ·Cristian A. Lasagna‐Reeves, Diana L. Castillo‐Carranza, Urmi Sengupta, Audra L. Clos, George R. Jackson, Rakez Kayed	467
8	Role of oligomers in the amyloidogenesis of primary cutaneous amyloidosis 2011 ·Journal of the American Academy of Dermatology ·Audra L. Clos, Cristian A. Lasagna‐Reeves, Brent Kelly, Richard F. Wagner, Michael G. Wilkerson, George R. Jackson, Rakez Kayed	10
9	Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis 2011 ·British Journal of Dermatology ·Audra L. Clos, Cristian A. Lasagna‐Reeves, Diana L. Castillo‐Carranza, Urmi Sengupta, George R. Jackson, Brent Kelly, Thomas M. Beachkofsky, Rakez Kayed	9
10	Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice 2010 ·Biochemical and Biophysical Research Communications ·Cristian A. Lasagna‐Reeves, Dennisse Gonzalez-Romero, Marcelo A. Barria, Ivonne Olmedo, Audra L. Clos, V. M. Sadagopa Ramanujam, Akihiko Urayama, Leoncio Vergara, Marcelo J. Kogan, Claudio Soto	461
11	Therapeutic removal of amyloid deposits in cutaneous amyloidosis by localised intra‐lesional injections of anti‐amyloid antibodies 2010 ·Experimental Dermatology ·Audra L. Clos, Cristian A. Lasagna‐Reeves, Richard F. Wagner, Brent Kelly, George R. Jackson, Rakez Kayed	11
12	Inhaled Insulin Forms Toxic Pulmonary Amyloid Aggregates 2010 ·Endocrinology ·Cristian A. Lasagna‐Reeves, Audra L. Clos, Terumi Midoro‐Horiuti, Randall M. Goldblum, George R. Jackson, Rakez Kayed	37
13	Viral Upper Respiratory Tract Infection and Otitis Media Complication in Young Children 2008 ·Clinical Infectious Diseases ·Tasnee Chonmaitree, Krystal Revai, James J. Grady, Audra L. Clos, Janak A. Patel, Sangeeta Nair, Jun Fan, Kelly J. Henrickson	286

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact